PARP inhibitor Niraparib tosylate, Purity ≥98%

Cat. No.: X23-10-ZQ221

PARP inhibitor Niraparib tosylate, Purity ≥98%

Synonym: 1038915-73-9; MK-4827 tosylate; Niraparib tosylate; MK-4827 (tosylate); MK-4827-tosylate; UNII-75KE12AY9U; (S)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide 4-methylbenzenesulfonate; PARP inhibitor

  • CAS Number: 1038915-73-9
  • Compound CID: 78357761
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Niraparib tosylate, soluble in DMSO and insoluble in ethanol and water, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks.
Molecular Weight
492.59
Molecular Formula
C26H28N4O4S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 86 mg/mL (174.58 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Niraparib tosylate can be used to study its effects as a PARP inhibitor in cancer therapy.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.